Prognostic models in myelodysplastic syndromes

被引：2
|
作者：
Della Porta, Matteo Giovanni [1 ,2 ]
机构：
[1] Fdn Ist Ricovero Cura & Carattere Sci IRCCS Polic, Dept Hematol Oncol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 06期
关键词：
SCORING SYSTEM; MUTATIONS;
D O I：
10.1016/S2352-3026(15)00110-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E229 / E230
页数：2
相关论文
共 50 条
  • [21] Myelodysplastic Syndromes
    Stehle, Gregor
    Schwarb, Heike
    Passweg, Jakob R.
    THERAPEUTISCHE UMSCHAU, 2019, 76 (09) : 497 - 502
  • [22] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
    Duong, Vu H.
    Padron, Eric
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Hall, Jeff
    Kwok, Brian
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    List, Alan F.
    Komrokji, Rami S.
    ANNALS OF HEMATOLOGY, 2018, 97 (02) : 247 - 254
  • [23] Prognostic implications in myelodysplastic syndromes: A review of 62 cases
    Higuchi, T
    Mori, H
    Niikura, H
    Omine, M
    Fujita, K
    LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) : 479 - 484
  • [24] Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
    Tefferi, Ayalew
    Gangat, Naseema
    Mudireddy, Mythri
    Lasho, Terra L.
    Finke, Christy
    Begna, Kebede H.
    Elliott, Michelle A.
    Al-Kali, Aref
    Litzow, Mark R.
    Hook, C. Christopher
    Wolanskyj, Alexandra P.
    Hogan, William J.
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Zblewski, Darci L.
    He, Rong
    Viswanatha, David
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Tang, Jih-Luh
    Chou, Wen-Chien
    Lin, Chien-Chin
    Tsai, Cheng-Hong
    Tien, Hwei-Fang
    Hou, Hsin-An
    MAYO CLINIC PROCEEDINGS, 2018, 93 (10) : 1363 - 1374
  • [25] Overview of Myelodysplastic Syndromes
    Beris, Photis
    Georgiou, George
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 287 - 294
  • [26] Myelodysplastic syndromes (MDS)
    Germing, U.
    Kuendgen, A.
    Haas, R.
    Gattermann, N.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (05) : 183 - 185
  • [27] Clofarabine for myelodysplastic syndromes
    Tiu, Ramon V.
    Traina, Fabiola
    Sekeres, Mikkael A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (07) : 1005 - 1014
  • [28] The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
    Nazha, Aziz
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    Barnard, John
    Roboz, Gail J.
    Steensma, David P.
    DeZern, Amy E.
    Zell, Katrina
    Zimmerman, Cassie
    Al Ali, Najla
    Jabbour, Elias
    Greenberg, Molly D.
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    List, Alan F.
    Sekeres, Mikkael A.
    HAEMATOLOGICA, 2016, 101 (06) : E224 - E227
  • [29] Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes
    Falco, Patrizia
    Levis, Alessandro
    Stacchini, Alessandra
    Ciriello, Maria M.
    Geuna, Massimo
    Notari, Patrizia
    Omede, Paola
    Pautasso, Marisa
    Prato, Giuseppina
    Strola, Giuliana
    Gioia, Daniela
    Bonferroni, Margherita
    Cametti, Gianni
    Ferrero, Dario
    Freilone, Roberto
    Gaidano, Gianluca
    Marinone, Carlo
    Marmont, Filippo
    Pollio, Berardino
    Salvi, Flavia
    Saglio, Giuseppe
    Girotto, Mauro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (05) : 409 - 418
  • [30] Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes
    Kuendgen, A.
    Gattermann, N.
    Germing, U.
    LEUKEMIA, 2009, 23 (01) : 182 - 184
12345